BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  HemoShear, LLC Hires Industry Business Development Veteran Vincent Aurentz as Chief Business Officer

  August 6, 2013

   · 

  2 min read
• A*STAR: Unexpected Synergy Between Two Cancer-Linked Proteins Offers Hope for Personalized Cancer Therapy

  August 6, 2013

   · 

  6 min read
• Lightlake Therapeutics Inc. Retains KCSA Strategic Communications as Corporate Communications Advisors

  August 6, 2013

   · 

  3 min read
• FDA

  Alere Inc. MobileLink Receives FDA Clearance

  August 6, 2013

   · 

  3 min read
• Drug Development

  The Medicines Company Announces Positive Phase III Trial Results for Fibrocaps; Completes ProFibrix Acquisition

  August 6, 2013

   · 

  7 min read
• Business

  Jazz Pharmaceuticals plc and Alkermes plc are Seen as Next Targets Amid Irish Deal Frenzy: Real M&A

  August 6, 2013

   · 

  1 min read
• FDA

  FDA’s Cardiovascular and Renal Drugs Advisory Committee Recommends Not to Approve Otsuka Pharmaceutical Co., Ltd.'s Tolvaptan for Use in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  August 6, 2013

   · 

  5 min read
• Business

  Hyperion Therapeutics Announces Larry J. Singer as Vice President, Manufacturing

  August 6, 2013

   · 

  1 min read
• Business

  Celldex Therapeutics, Inc. Reports Second Quarter 2013 Financial Results

  August 6, 2013

   · 

  1 min read
• Policy

  FDA Approves BioGaia’s Request for Orphan Drug Designation

  August 6, 2013

   · 

  1 min read